Clinical Trial Update: Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma [Phase 3]

View source ↗

Summary

This update describes a Phase 3 clinical trial evaluating paclitaxel in combination with pegylated liposomal doxorubicin for HIV-related Kaposi sarcoma. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Kaposi Sarcoma, HIV-1-infection | Phase 3 | Status: NOT_YET_RECRUITING